Trade Gilead GILD

Sell
 Buy

Gilead live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Gilead News

Sophia Claire 2025 Dec 05, 00:01

Trump's Fed Chair Pick: Power Plays and Monetary Policy in 2025

Noah Lee 2025 Dec 05, 00:00

Diverging Fed Rate Hike Expectations: Will the Fed Defy Forecasts?

Sophia Claire 2025 Dec 05, 00:00

PC Prices Projected to Surge by 2026 Amid AI-Driven Memory Shortage

Noah Lee 2025 Dec 05, 00:00

Gold Outlook 2026: Analyzing Scenarios and Potential Market Impacts

Ghko B 2025 Dec 04, 16:00

Bitcoin price prediction: BTC/USD rebounds, is BTC expected to rise further?

Ghko B 2025 Dec 04, 16:00

Nio stock price prediction: NIO jumps today, will this rally accelerate?

Ghko B 2025 Dec 03, 16:00

Stock opportunities for 2026: TSMC Stock, CRCL Stock, IONQ Stock, NIO

Ghko B 2025 Dec 03, 16:00

Best S&P 500 ETF to buy: Vanguard S&P 500 ETF (VOO), SPY, IVV, iShares ETFs

Ghko B 2025 Dec 03, 16:00

Best CFD Brokers: Award-winning CFD Platforms, markets.com, IG, Pepperstone

Noah Lee 2025 Nov 10, 09:10

x402 Ecosystem Competition Analysis: Launchpads, Facilitators, and Providers

Latest news

Show more
Noah Lee 2025 Dec 05, 17:40

Polymarket Builds Internal Market-Making Team Amid Regulatory Scrutiny

Noah Lee 2025 Dec 05, 16:30

Poland's Crypto Regulation Stalled: MiCA Alignment Implications

Emma Rose 2025 Dec 05, 15:50

Do Kwon Faces Potential 12-Year Prison Sentence in Terraform Labs Collapse

Liam James 2025 Dec 05, 15:10

Texas Buys Bitcoin: Long-Term Strategy or Short-Term Gamble?

Noah Lee 2025 Dec 05, 13:40

Beyond 'Buy the Dip': Institutional Crypto Investment Strategies

Noah Lee 2025 Dec 05, 13:10

The Future of Web3 Wallets: 5 Key Areas of Focus

Sophia Claire 2025 Dec 05, 12:50

Solana Presale Plagued by Bot Attack: WET Token Launch Scrapped

Noah Lee 2025 Dec 05, 12:20

Paribu Acquires CoinMENA: A Strategic Move into the MENA Crypto Market

Info

Spread

0.74

Spread (%)

0.6114 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Friday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

155100856320

Shares Outstanding

1240679623

Earnings Date (Next)

2013-01-28

Div Yield

2025-12-30

Ex-Dividend Date

2025-12-15

Forward annual dividend rate

3.16

Forward annual dividend yield

0.0253

EPS

6.46

Learn more about this instrument

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Dec 04, 16:00

How to trade gold: Trading tips on gold CFDs, Short-term trades in XAU/USD

Ghko B 2025 Dec 03, 16:00

What are the most traded indices: how to trade indices CFD with markets.com?

Ghko B 2025 Dec 03, 16:00

Start investing in 2026: trader's guide, how to find the best CFD broker?

Trustpilot